ClinicalTrials.Veeva

Menu

Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors (TRIPLE-A)

C

Centre Francois Baclesse

Status

Completed

Conditions

Musculoskeletal Pain
Breast Cancer

Treatments

Device: Auriculotherapy for analgesic use
Device: Placebo auriculotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03096041
TRIPLE-A

Details and patient eligibility

About

Auriculotherapy is a complementary medicine, with few side effects, without contraindication, inexpensive and not very restrictive.Its efficacy has been found in several tests especially for the treatment of intraoperative pain. It remains more controversial in other indications. Evaluation of the value of auriculotherapy is often difficult because of the methodological limitations of the trials conducted. In the daily practice, the auriculotherapy is proposed to improve the articular pains of patients treated by AA. This Phase III study aims at validate this approach.

Enrollment

197 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years of age
  • Patients with anti-aromatases in adjuvant treatment of breast cancer
  • Menopausal women
  • Treatment with aromatase inhibitors (anti-aromatase, AA) initiated for more than 3 months. In the case of a change in anti-aromatase, the last treatment must be started for more than 3 months.
  • Musculoskeletal pain appearing or increased under AA:
  • Overall pain score of QCD ≥3 (on a scale of 0 to 10)
  • Pain on at least 2 sites
  • Pain for at least 3 months
  • History of radiotherapy and / or adjuvant chemotherapy authorized
  • Patients may have received tamoxifen
  • Patient affiliated to a social security system
  • Patient mastering the French language and able to complete the evaluation questionnaires
  • Free and Informed Consent

Exclusion criteria

  • Patients who have already undergone treatment in auriculotherapy for the same indication
  • Patient benefiting at the same time from a PNCAVT (acupuncture or homeopathy) for musculoskeletal pain
  • Wearing hearing aids hindering the placement of semi-permanent needles (ASP)
  • Wearing of a valve prosthesis
  • Patient under guardianship or unable to give informed consent
  • Patient unable to undergo medical follow-up for geographical, social or psychopathological reasons

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

197 participants in 2 patient groups, including a placebo group

Experimental arm
Experimental group
Description:
Auriculotherapy for analgesic use
Treatment:
Device: Auriculotherapy for analgesic use
Controle arm
Placebo Comparator group
Description:
Placebo auriculotherapy
Treatment:
Device: Placebo auriculotherapy

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems